University of California San Francisco
Give to UCSF
The new UCSF Health-John Muir Health Jean and Ken Hofmann Cancer Center at the Behring will bring a full spectrum of leading-edge cancer care close to home for people in the East Bay and surrounding areas.
Cancer immunotherapy is hindered by the fact that engineered immune cells often get worn out and depleted before they've killed a tumor. A UCSF team has identified mutations that give cancerous lymphoma T-cells their superpower and transfer those genes into engineered, therapeutic immune cells.
The two-year HEAL fellowship initiative operates in 10 countries but has a special focus on serving the Navajo Nation, which continues to suffer from the consequences of colonialism, including poor access to health care.
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
A grief facilitator and UCSF chaplain shares some advice on processing loss.
Cell biologist and engineer Matthew Kutys, PhD, and his team harness organoids – living tissues derived from patient tumors – to study how cancer spreads.
What a tiny grassroots program in the Tenderloin is teaching doctors about healing through human connection.
The UCSF Department of General Internal Medicine’s food pharmacy gives out bags of fresh produce and a protein item twice a month and offers a cooking class and hot meals once a month for patients who experience food insecurity.
Eric J. Small, MD, UCSF professor of Medicine and Urology Credit: UCSFThe American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term
Researchers at UCSF and UC Berkeley are investigating the impact of pre- and post-natal exposures to tobacco smoke on the survival rate of children with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
